SCN5A mutations associated with overlap phenotype of long QT syndrome type 3 and brugada syndrome

Circulation Journal

Volumn 78, Issue 5, 2014, Pages 1061-1062

  Nakaya, Haruaki ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE; MEXILETINE; POTASSIUM CHANNEL HERG; QUINIDINE; SODIUM CHANNEL NAV1.5;

BRUGADA SYNDROME; EDITORIAL; GENE; GENE MUTATION; HUMAN; LONG QT SYNDROME 3; SCN5A GENE; ST SEGMENT ELEVATION;

EID: 84899626851     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0319     Document Type: Editorial

References (10)

1. Remme CA, Wilde AAM, Bezzina CR. Cardiac sodium channel overlap syndromes: Different faces of SCN5A mutations. Trend Cardiovasc Med 2008; 18: 78-87.
2. Makita N. Phenotypic overlap of cardiac sodium channelopathies: Individual-specific or mutation-specific? Circ J 2009; 73: 810-817.
3. Bezzina C, Veldkamp MW, van den Berg MP, Postma AV, Rook MB, Viersma J-W, et al. A single Na+ channel mutation causing both long-QT and Brugada syndromes. Circ Res 1999; 85: 1206-1213.
4. Grant AO, Carboni MP, Neplioueva V, Starmer F, Memmi M, Napolitano C, et al. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J Clin Invest 2002; 110: 1201-1209.
5. Makita N, Behr E, Shimizu W, Horie M, Sunami A, Crotti L, et al. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest 2008; 118: 2219-2229.
6. Kanters JK, Yuan L, Hedley PL, Stoevring B, Jons C, Thomsen PEB, et al. Flecainide provocation reveals concealed Brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A. Circ J 2014; 78: 1136-1143.
7. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 2013; 15: 1389-1406.
8. Shimizu W. Update of diagnosis and management of inherited cardiac arrhythmias. Circ J 2013; 77: 2867-2872.
9. Veerakul G, Nademanee K. Brugada syndrome: Two decades of progress. Circ J 2012; 76: 2713-2722.
10. Fredj S, Sampson KJ, Liu H, Kass RS. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: Evidence for site of action. Br J Pharmacol 2006; 148: 16-24